Business
DECN Continues to Add GenViro! Dealers With an Agreement Covering Puerto Rico, the Dominican Republic, the US Virgin Islands and Geographies Across the Caribbean and Central America
DECN Continues to Add GenViro! Dealers With an Agreement Covering Puerto Rico, the Dominican Republic, the US Virgin Islands and Geographies Across the Caribbean and Central America.
About this update from Decision Diagnostics Corp
[{"type":"text","content":"Company Being Sought Out Worldwide for Global Distribution Agreements as It Enters the "Home Stretch" in U.S.- Based Testing at FDA & CLIA Certified LabLOS ANGELES, CA / ACCESSWIRE / November 6, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., today announced it has signed a number of distribution agreements for its GenViro! Covid-19 10.5 Second Saliva Swift Kits covering Puerto Rico, the Dominican Republic, the US Virgin Islands and areas across the Caribbean and Central America. GenViro! Swift cannot yet be sold in Puerto Rico. This most recent announcement comes less than a week after the company announced it had signed agreements with distributors/dealers covering Nigeria, Ivory Coast and Lebanon. This heightened number of additional distributor/dealer agreements comes while the company enters what it has referred to as the "home stretch" in its FDA testing submission efforts utilizing the assistance of a Pennsylvania-based FDA and CLIA certified testing lab."We are pleased with the further demonstration of interest on a global scale in Genviro! and will continue to rapidly assess each inquiry. As I have said previously, we are also in discussions with several of our large GenUltimate distributors who have expressed interest in having, after FDA authorization, Genviro! added to their Amazon professional use product offerings," said CEO Keith Berman.GenViro! Swift kits are not yet available for sale in the USA or Puerto Rico. Emergency FDA Authorization is in processABOUT DECISION DIAGNOSTICS CORPDecision Diagnostics Corp. is the leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters. DECN's products are designed to operate efficiently and less expensively on certain glucose meters already in use by almost 7.5 million diabetics worldwide. With newly inspired technology, and diabetic test strips already in the final stages of development, DECN products compete on a worldwide scale with legacy manufacturers currently selling to 71+ percent of a $15+ billion at-home testing market.The company's new GenViro!™ products desig...